NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 57.74

-2.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (235)	6/8/2007 12:15:18 PM
From: Arthur Radley	Read Replies (1) of 507

In current issue of Kiplinger's magazine they have interiew with Bill Miller(Legg,Mason), the top stock picker in beating the S&P averages until losing out for the first time last year when he didn't. Anyway, one of his current picks in (MANN). His justification is that their "inhaler" will be smaller than (NKTRs) and he expects their market share to be in the billions. IMO Miller is barking up the wrong tree...it isn't the size that caused NKTRs problems, it's doctors having concerns about the safety of long term use of a inhaled drug.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next